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Abstract
Epinephrine autoinjectors (EAIs) are important first aid medications for treating anaphylaxis. A 10-fold price increase over the
past 12 years and evidence that expired EAIs may still contain significant doses of available epinephrine have motivated interest
in the efficacy of expired EAIs as treatments of last resort. Degradation of expired EAIs, which can be caused by improper storage
conditions, results in various degrees of discoloration of the epinephrine solution. Previous studies have determined that signif-
icant epinephrine remains available in expired EAIs, but these have only considered EAIs that show no discoloration. Here, we
investigate the potential for colorimetric estimation of available epinephrine dose based on the degree of discoloration in expired
EAIs. The correlation of available epinephrine dose and time since expiration date was poor (r = − 0.37), as determined by an
industry standard UHPLC protocol. Visible absorbance of the samples integrated across the range 430–475 nm correlated well
with available epinephrine dose (r = − 0.71). This wavelength corresponds to the blue channel of a typical smartphone camera
Bayer filter. Smartphone camera images of the EAI solutions in various illumination conditions were analyzed to assign color
indices representing the degree of discoloration. Color index of the samples showed similar correlation (|r| > 0.7) with available
epinephrine dose as that of visible spectrophotometry. Smartphone imaging colorimetry is proposed as a potential point-of-use
epinephrine dose estimator for expired and degraded EAIs.
Keywords Epinephrine autoinjector (EAI) . Ultra-high-performance liquid chromatography (UHPLC) . Quantitative smartphone
imaging . Point-of-care method
Introduction
Epinephrine is widely used as a first aid drug for the treatment
of anaphylaxis [1, 2]. Anaphylaxis can be triggered by a wide
variety of stimuli including food, medication, and envenom-
ation [3–7]. Anaphylaxis shows signs of hyperallergic reac-
tions in quick successions and can lead to death [8, 9].
Epinephrine induces vasoconstriction which helps reduce or
prevent upper airway mucosal edema, hypotension, and
shock. Epinephrine also has important bronchodilator effects
that help relieve laryngospasm, bronchospasm, and cardiac
inotropic and chronotropic effects, which also helps in treating
hypotension and shock [8]. Fatality in cases of anaphylaxis is
correlated with delayed epinephrine administration [9].
Immediate recognition of anaphylaxis and ability to adminis-
ter epinephrine are vital to saving lives in cases of anaphylax-
is, which is whymany people prone to severe allergic reaction,
as well as first aid providers, carry epinephrine autoinjectors
(EAIs). Still, studies suggest that underuse of epinephrine as a
first aid drug in cases of anaphylaxis is a significant problem
[10].
EAIs typically contain 1 mg mL−1 epinephrine
(0.5 mg mL−1 for EpiPen Junior) in saline solution and are
marked with expiration dates after which administration of the
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drug is not recommended [11]. Recent price increases of com-
mercial EAIs have triggered interest in the efficacy of expired
EAIs. In 2007, average EAI price increased 545% to $350
[12] and by 2016 the price was $600 [13]. A study on patient
compliance reported that even patients with high awareness of
EAI expiration date may still carry expired EAIs and delay
replacement [14, 15]. Several studies have found 50–90%
active ingredient still available in EAIs from 1 to 90 months
after their expiration dates [16–18].
Epinephrine oxidizes in the presence of atmospheric oxy-
gen, taking on a pink to brown appearance depending on the
extent of oxidation [19]. Similar degradation of EAI contents
was observed after prolonged heat exposure [20]. There is
evidence to suggest that epinephrine degradation products
are well tolerated in the body. Ocular epinephrine drugs can
cause pigmentation of the conjunctiva [21, 22] and cornea
[21–25] due to epinephrine degradation products produced
upon light exposure [26, 27]. The oxidized derivative of epi-
nephrine is melanin-like adrenochrome [23, 28], and the
resulting discoloration of the eye is tolerated as a side effect
of ocular epinephrine drugs [27]. Although it is advised to not
use discolored EAIs [11, 16, 18], the prevalence of expired
EAIs due to cost pressures, and the nature of epinephrine as a
drug of first aid, presents the possibility that expired and
discolored EAIs can be the only option available in emergency
and remote settings.
Austere medicine is the practice of medicine in
resource-constrained environments, from wilderness areas
in North America to third world countries [29]. In austere
environments, the ability to procure fresh medicine can be
severely hampered, and the conundrum of using whatever
medicine is available becomes the issue. Epinephrine is a
life-saving drug for patients experiencing anaphylaxis
and, if the medicine is discolored or out of date, waiting
for replacement epinephrine may not be a viable option.
The safety and efficacy of expired and discolored EAIs is
not well established, and the current accepted practice is
that discolored EAIs should not be administered. Still,
austere medical scenarios exist in which discolored med-
ication will be administered, and in such cases the ability
to assess the concentration of epinephrine in discolored or
expired EAIs using ubiquitous and readily available
smartphone technology may save lives.
Simons and coworkers determined the available active in-
gredient in expired EAIs [18]. 28 EpiPens and 6 EpiPen
Juniors were investigated via spectrophotometry and HPLC.
Nearly all samples were colorless and free from precipitates,
and all contained at least 50% of the intended epinephrine
dose. They concluded that using an expired EAI during an
emergency outweighs the potential risk of giving no treat-
ment, presuming no signs of degradation are observed [18,
30]. These studies did not consider extensively expired EAIs
that showed substantial degrees of discoloration.
Smartphone imaging is emerging as an approach to color-
imetric detection for quantitative analysis. Blood glucose con-
centration in diabetic patients [31], electrolytes concentration
in human sweat [32], and alkaline phosphate concentration in
dairy [33] and serum [34] samples have been quantified via
smartphone images. Smartphone imaging has also been uti-
lized in applications such as detecting nucleic acids [35], in-
fluenza virus counting [36], immunoassay of prostate specific
antigens [37], and detection of Hg2+ via smartphone fluores-
cence microscopy [38–40].
We hypothesized that discolored EAIs present the opportu-
nity for simple colorimetric estimation of the available epi-
nephrine dose by quantitative smartphone imaging, which
may facilitate the evaluation of EAIs at the point of care.
Here, we investigated expired EAIs showing various degrees
of discoloration with the objectives of (1) determining the
correlation between available epinephrine and the time
elapsed since expiration date, (2) determining the correlation
between available epinephrine and the degree of discoloration,
and (3) developing a simple colorimetric methodology that
utilizes smartphone imaging to estimate available epinephrine
dose in discolored EAI solutions.
Experimental section
Reagents and materials
Epinephrine, methanol, 1-octanesulfonic acid, 1 mL polypro-
pylene syringes, and 0.22 μm nylon syringe filters were from
Fisher Scientific (Suwanee, GA). All aqueous solutions were
prepared with 18.2 MΩ water from a Milli-Q purification
system (Millipore, Bedford, MA). The Luna C18 chromatog-
raphy column (50 × 4.6 mm, 5 μm particle size, 100 A0 pore
size) was from Phenomenex Inc. (Torrance, CA).
Expired EAI samples
Multiple EAIs were obtained from various sources.
Expired EAIs were requested, without reference to stor-
age, and it is assumed that most, if not all the EAIs, were
carried by patients or EMS in non-temperature controlled
environments. After receipt of the EAIs, all syringe units
were carefully removed from their delivery unit, placed in
sealed Falcon tubes, and stored at room temperature until
assayed. Researchers developing the protocols and ana-
lyzing the epinephrine samples were blinded to the expi-
ration date until after analysis. These samples represent a
real world scenario of EAI storage rather than using EAIs
from controlled environments. Time since expiration date
for all the EAIs ranged from 12 to 207 months.
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Epinephrine measurements by UHPLC
The samples were filtered through 0.22 μm nylon syringe
filters to eliminate any particulates. The filtrates were diluted
to 20% of original concentration with 50% methanol in water
solution. Epinephrine concentrations were determined using
an Agilent 1290 infinity series (Agilent Technologies, Inc.,
Santa Clara, CA) ultra-high-pressure liquid chromatography
(UHPLC) instrument equipped with a diode array detector
following a US Pharmacopeia (USP) standard protocol [41].
Briefly, isocratic elution was conducted on a C18 column at
1 mL min−1 with a mobile phase of 1:1 methanol/water with
0.1% 1-octanesulfonic acid added as an ion-pairing agent. UV
absorbance was recorded at 278 nm. Epinephrine standard
solutions were used to produce a calibration curve in the range
from 0.01–1.00 mg mL−1. The concentrations of epinephrine
in EAI samples were determined by fitting the resultant peak
area to the best fit line of the calibration data.
Characterization by UV-Vis spectrophotometry
UV-Vis spectra of the EAI samples were obtained using a
NanoDrop One spectrophotometer (Thermo Fisher
Scientific, Waltham, MA). The absorbance maximum of
278 nm for epinephrine was determined using epinephrine
standard solutions, and a calibration curve was constructed
in the concentration range of 0.01 to 1.00 mg mL−1. EAI
samples were diluted to 20% of original concentration to fall
within the calibration range. Epinephrine concentrations for
expired EAI samples were determined via absorbance at
278 nm by fitting to the best fit line of the calibration data.
Quantitative smartphone imaging
Color index was defined as the integrated absorbance of the
spectral region 430–475 nm, which corresponds to the blue
bandpass component of a common photographic Bayer filter
[42]. Smartphone images of the EAI samples were obtained
with a Motorola G5S plus device. The Open Camera android
application (http://opencamera.org.uk) was used to hold white
balance and exposure time constant for all images taken under
a particular lighting condition. EAI samples were imaged
within standard 1 mL polypropylene syringes in four
different lighting conditions: ambient sunlight, fluorescent
office illumination with smartphone flashlight, fluorescent
office illumination without smartphone flashlight, and under
dark lab conditions while utilizing the smartphone flashlight.
Results and discussion
Twenty-three expired EAIs, ranging from 12 to 207 months
past expiration date, were characterized to determine available
epinephrine dose. UHPLC analysis of epinephrine standard
solutions via a standardized USP protocol gave a peak at
2.86 ± 0.01 min (Fig. 1a). The EAI samples were observed
as a range of colored solution from clear to black and were
qualitatively categorized into four groups, clear, pink, brown,
and black, based on their appearance to the naked eye.
Figure 1b–e shows representative chromatograms of samples
from each qualitative category. All samples showed a peak at
approximately 2.9 min, indicative of available epinephrine in
the EAI solution. Increasing color intensity correlated with an
increase in additional peaks eluting in the range of 1–2 min.
We postulate that these additional peaks are epinephrine deg-
radation by-products, although further study is needed to iden-
tify these constituents. EAI samples were evaluated by
UHPLC in triplicate to yield concentration determinations
with RSD < 5% in all cases. In this study, epinephrine con-
centrations in expired EAIs were found to be in the range of
0.05–1.43 mg mL−1. Although it was unexpected to observe
epinephrine concentrations higher than the reported dose of
1 mg mL−1, and the nature of this discrepancy is not immedi-
ately clear, this finding corroborates those of Simons and co-
workers who measured epinephrine concentrations as high as
1.19 mg mL−1 [18]. We found that time since expiration date
was a poor predictor of available epinephrine dose in
discolored EAIs. Simons and coworkers found a Pearson cor-
relation coefficient (r) of − 0.63 indicating moderate correla-
tion between available epinephrine dose and time since expi-
ration date in expired EAIs that had been stored appropriately
to prevent sample discoloration and formation of particulates
[18]. For discolored EAI solutions, we observed poor correla-
tion (r = − 0.37) of available epinephrine dose with time since
expiration date (Fig. 1f).
As an initial investigation into the efficacy of photometry
for EAI characterizations, epinephrine concentrations were
determined by UV-Vis spectrophotometry of the same filtered
EAI samples used for UHPLCmeasurements. UVabsorbance
spectra are shown in Fig. 2a for the same representative sam-
ples shown in Fig. 1b–e, with an additional trace showing an
epinephrine standard solution of concentration 0.4 mg mL−1.
EAI epinephrine concentrations were determined via calibra-
tion of UVabsorbance at 278 nm.
Figure 2b shows the comparison of epinephrine concentra-
tions determined by UV spectrophotometry with those deter-
mined by the standard UHPLC protocol. UVabsorbance con-
sistently overestimated epinephrine concentrations, which is
evident from the mostly positive residual values shown in the
residual plot of Fig. 2c. We hypothesize that the inaccuracy of
UVabsorbance in determining epinephrine concentration is a
result of spectral overlap between degradation products in
solution and epinephrine, which is supported by the observa-
tion of non-epinephrine peaks in the chromatograms of de-
graded EAI samples with absorbance detection at 278 nm
(see Fig. 1b–e). Importantly, UV absorbance was measured
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using filtered samples, which eliminated particulate matter
and had the effect of reducing, although not eliminating en-
tirely, the intensity of discoloration as observed by the naked
eye. Filtration was necessary prior to UHPLC and was conve-
nient for avoiding aberrant scatter in UVabsorbance measure-
ments, but it poorly approximated the conditions of expired
EAI solutions at the point of use.
We hypothesized that colorimetry of the unfiltered, and
thus more intensely colored, expired EAI samples would
yield a more effective correlation with epinephrine con-
centration. Unfiltered samples appeared with various red
hues ranging from pink to dark brown; thus, we investi-
gated absorbance in the blue region of the visible spectra.
Figure 3a shows the UV-visible spectra in the range 175–
850 nm and an enlarged view of the range 430–475 nm
(inset), which corresponds with the typical bandpass
range of the blue component of a Bayer filter found in
many digital cameras [43].
The trend of integrated absorbance across the range 430–
475 nm corresponded with the trend of discoloration intensity,
shown in Fig. 3b, and with the trend of epinephrine concen-
trations as determined by UHPLC (given in Fig. 3a color
legend), whereas absorbance at 278 nm did not show the same
correlation with the trend of epinephrine concentrations.
The integrated area of the absorbance spectrum from
430 nm to 475 nm was calculated for each sample, and we
termed this value the color index. All measured color index
values were normalized by dividing by the highest measured
color index to give the relative color index, which has a max-
imum possible value of 1. Figure 4 shows the correlation
between epinephrine concentration as determined by
UHPLC and the relative color index value. A significant
Fig. 1 Epinephrine quantitation
by UHPLC: representative
chromatograms of a pure
epinephrine standards, b expired
EAI sample that appeared black, c
expired EAI sample that appeared
brown, d expired EAI sample that
appeared pink, e expired EAI
sample that appeared clear, and f
Poor correlation (r = − 0.37) was
observed for epinephrine
concentration in expired and
discolored EAI samples vs. time
elapsed since expiration date
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negative correlation is observed as characterized by a Pearson
correlation coefficient of − 0.71. This negative correlation
suggests that colorimetry of the unfiltered degraded EAI sam-
ples may offer an effective approach for estimating epineph-
rine concentration.
To demonstrate the efficacy of smartphone imaging for
colorimetric assay of degraded EAIs, solutions were trans-
ferred into standard 1 mL polypropylene syringes and imaged
via smartphone camera. Imaging conditions were standard-
ized by utilizing a sheet of standard A4 printer paper as an
imaging background, and multiple illumination conditions
were investigated.
Each colored image was decomposed into three gray-
scale images representing the red, green, and blue compo-
nents (i.e., converted to “RGB stack”) using the open
source imaging application Fiji [44]. Mean grayscale in-
tensities from the blue image channel in specific regions
of interest were used to determine an approximated color
index value as follows:
Color index ¼ log10
I0
I
where I0 is the mean grayscale intensity from a represen-
tative region of interest on the white background, and I is
the mean grayscale intensity from a representative area of
the syringe as indicated in Fig. 5a–d. This image analysis
was performed on images collected outdoors under ambi-
ent sunlight (Fig. 5a, e), under fluorescent office illumi-
nation with the addition of smartphone flashlight illumi-
nation (Fig. 5b, f), under fluorescent office illumination
without the addition of smartphone flashlight illumination
(Fig. 5c, g), and under dark conditions while utilizing the
smartphone flashlight (Fig. 5d, h). As with the data shown
in Fig. 3, all calculated color index values were normal-
ized to the highest measured color index to give relative
color index. Under all illumination conditions, similar
negative correlations are observed between the measured
color index and the epinephrine dose as determined via
the standard UHPLC protocol, with r ranging from − 0.71
to − 0.77. Following the methodology of Watters and co-
workers [45], the calibration plots in Fig. 5e–h were each
fitted with a 95% confidence band to estimate confidence
interval as a function of epinephrine concentration (see
the Electronic Supplementary Material (ESM), Fig. S1).
Fig. 2 Epinephrine quantitation
by UV spectrophotometry: a
representative UVabsorbance
spectrum of discolored EAI
samples and an epinephrine
standard solution at 0.4 mg mL−1,
b comparison of epinephrine
concentrations determined by UV
spectrophotometry vs. those
determined by the industry
standard UHPLC protocol, and c
residual plot of epinephrine
concentrations of EAI samples
from UV spectrophotometry vs.
concentrations determined by
UHPLC
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The estimated 95% confidence interval at 1 mg mL−1 epi-
nephrine ranged from ± 0.12 to ± 0.15 mg mL−1 for all
lighting conditions studied here, indicating that, depen-
dent on lighting conditions, a 12–15% reduction in report-
ed epinephrine dose can be detected with 95% confidence.
There are two important points to note here. First, these
calibrations are intended to demonstrate proof of princi-
ple, and further calibration from a wider variety of sample
sources is needed to deliver an assay with clinical utility.
Second, there are no empirical limits established on effec-
tive epinephrine dose because epinephrine dosing for the
treatment of anaphylaxis is not based on empirical study
of the dose-response relationship [46]. Therefore, no em-
pirical metric exists by which to determine whether the
demonstrated assay performance is sufficient for clinical
utility. Still, in-date EAIs have been reported to contain in
the range of 86–114% of the stated epinephrine dose [18]
indicating that the current assay can determine epineph-
rine dose degradation to within the accuracy of dosage of
unexpired EAIs.
A quantitative smartphone imaging assay can enable col-
orimetric estimation of epinephrine in environments where
imaging conditions could be difficult to control. Thus, we
investigated the robustness of this assay to sample position
and orientation with respect to the smartphone camera
(Fig. 6). Four representative samples of various hue (i.e., clear,
pink, brown, and black in appearance) were studied to deter-
mine the variation of color index as a function of the syringe
distance from the smartphone camera. We estimated that a
natural ergonomic range of camera-sample distance for hand-
held image acquisition was 15–45 cm, and images were re-
corded with the syringe placed at 7.5 cm increments within
that range. For all images, the white background was placed
3.8 cm behind the syringe, which we estimated as an appro-
priate distance to represent a syringe and white paper back-
ground held in the same hand approximately one-to-two
Fig. 4 Relative color index vs. epinephrine concentration: color index
correlates well with epinephrine concentration as determined by
UHPLC, giving a Pearson correlation coefficient of r = −0.71
Fig. 3 Visible spectrophotometry
of discolored EAI solutions: a
representative UV-Vis absorbance
spectrum of discolored EAI sam-
ples, labeled by epinephrine con-
centration determined via
UHPLC. The inset shows a mag-
nified view of the visible spectra
in the range 430–475 nm. b
Images of samples represented in
panel a. Color labels correspond
to the line colors of panel a
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finger widths apart. Figure 6a shows small but statistically
significant differences in color index for the clear sample only
when comparing images recorded at 22.5 cm to those record-
ed at 37.5 cm (p = 0.007). Statistically significant differences
were observed for the brown sample when comparing images
recorded at 30 cm to either those recorded at 15 cm (p = 0.002)
or those recorded at 45 cm (p = 0.01), but no other significant
differences were observed in the study of camera-sample dis-
tance. When color index values from all sample distances
were pooled for each sample color, RSD was 4.8%, 4.3%,
4.9%, and 2.9% for clear, pink, brown, and black samples,
respectively. This result suggests that, despite the small signif-
icant differences observed, the imaging assay is robust to
camera-sample distance in the range of 15–45 cm.
We estimated that an operator could reasonably approxi-
mate syringe orientation to within ± 20° of vertical. Thus, to
study the influence of syringe orientation, we collected sample
images with syringes oriented vertically and with 20° of tilt in
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Fig. 5 Quantitative smartphone imaging of discolored EAI solutions:
Representative images of EAI solutions illuminated via a ambient
sunlight, b fluorescent office illumination with smartphone flashlight, c
fluorescent office illumination without smartphone flashlight, and d dark
ambient conditions with smartphone flashlight illumination. Plots of
relative color index vs. epinephrine concentration under e ambient
sunlight (r = − 0.77), f fluorescent office illumination with smartphone
flashlights (r = − 0.76), g fluorescent office illumination without
smartphone flashlights (r = − 0.71), and h dark ambient conditions with
smartphone flashlight illumination (r = − 0.71). Black circles in a–d
indicate regions of interest that gave mean intensity values for R, G,
and B as indicated in each figure. Note smaller regions of interest were
used in panels b and d so as to avoid the effects of glare on the syringe
surface
Fig. 6 Influence of sample distance and orientation on color index
determinations: color index values were determined for representative
samples shown in Fig. 3 while varying a imaging distance and b
syringe orientation with respect to the camera. All bars within each
sample color were compared via paired two sample two-tailed t test,
and statistically significant differences (p < 0.05) were observed between
the bars indicated with an asterisk (*)
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the plane of the image (i.e., left and right tilt) and out of the
plane of the image (i.e., forward and back tilt). There were no
statistically significant differences observed when comparing
data from vertically oriented syringes with those tilted left or
right, within the plane of the image (data not shown). This is
unsurprising, since tilted orientation within the plane of the
image does not affect the path length of light from the white
background through the volume of the syringe. Statistically
significant reductions in color index value (p < 0.005) were
observed when comparing syringes tilted forward (i.e., toward
the camera) with either vertical or backward tilted syringe
images for the pink and brown samples only (Fig. 6b). The
origin of this phenomenon is not immediately clear, but we do
not attribute it to increased path length which would increase
the observed color index value.When color index values from
all sample orientations were pooled for each sample color,
RSD was 5.0%, 3.4%, 4.3%, and 7.5% for clear, pink, brown,
and black samples, respectively. Thus, the assay is robust to
sample orientation when the syringe is oriented within ± 20°
of vertical.
Conclusions
We investigated available epinephrine dose in expired and
discolored EAIs via the USP standard UHPLC methodology,
spectrophotometry, and quantitative smartphone imaging. We
found that time past expiration date is a poor predictor of
available epinephrine concentration when EAIs have degrad-
ed and become discolored. Although spectrophotometry is
employed for quality control in commercial epinephrine pro-
duction [47], UV absorbance at 278 nm did not accurately
estimate the epinephrine concentration in degraded EAIs, like-
ly due to the presence of degradation products with spectral
overlap with epinephrine. In discolored and unfiltered EAIs,
visible absorbance in the range 430–475 nm correlated well
with available epinephrine concentration, which enabled the
development of a quantitative smartphone imaging protocol.
A simple digital image processing procedure utilizing
smartphone images yielded a strong correlation (|r| > 0.7) with
epinephrine concentrations determined by standard UHPLC
protocols, and this strong correlation persisted under various
lighting conditions. Quantitative smartphone imaging was ro-
bust to moderate variations in sample-camera distance and
sample orientation, yielding color index determination with
RSD ≤ 7.5% in all cases studied.
The present work stops short of providing a point-of-use
analysis tool for several important reasons. First, although our
work demonstrates feasibility for quantitative imaging in var-
ious lighting conditions, a universal calibration that is normal-
ized for illumination and white balance conditions is still
needed. This presents a multivariate challenge that will form
the basis of future work in this area. Second, although the
digital image processing employed here is well within the
computational abilities of common smartphones, in the pres-
ent work digital image processing was accomplished offline
using a personal computer. Substantial development is needed
to package the image processing tasks along with an appro-
priate user interface into a simple-to-use smartphone applica-
tion. Again, we intend to address this challenge with future
work. Finally, and most importantly, the safety and efficacy of
administering discolored EAI drugs is not well established.
Although we postulate that the tolerance of discolored degra-
dation products in ocular epinephrine drugs suggests low tox-
icity of the degradation products, this determination requires
consideration by the wider medical community and lies well
beyond the scope of the present work. Still, the present work
establishes two key findings: (1) EAI discoloration can be
utilized as an indicator for approximating available epineph-
rine concentration and (2) EAI discoloration is readily quan-
tified via a simple and robust smartphone imaging procedure.
Acknowledgments We would like to thank Dr. Seth C. Hawkins MD for
his interest in the project and supplying the EAIs that were used in testing.
Funding information This work was supported by start-up funding pro-
vided by the University of Tennessee, College of Arts and Sciences, and
the Department of Chemistry.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflicts of
interest.
References
1. Simons FE. Epinephrine (adrenaline) in the first-aid, out-of-hospital
treatment of anaphylaxis. Novartis Found Symp. 2004;257:228–43
discussion 43–7, 76–85.
2. Lieberman A, Marks A, Peet A. Mark’s basic medical biochemis-
try: a clinical approach. 4th ed. Philadelphia: Wolters Kluwer
Health/Lippincott Williams & Wilkins; 2013.
3. Boden SR, Wesley Burks A. Anaphylaxis: a history with emphasis
on food allergy. Immunol Rev. 2011;242(1):247–57.
4. Golden DB, Marsh DG, Kagey-Sobotka A, Freidhoff L, Szklo M,
Valentine MD, et al. Epidemiology of insect venom sensitivity.
JAMA. 1989;262(2):240–4.
5. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United
States. J Allergy Clin Immunol. 1973;52(5):259–64.
6. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R,
Chowdhury BA, et al. Symposium on the definition and manage-
ment of anaphylaxis: summary report. J Allergy Clin Immunol.
2005;115(3):584–91.
7. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics.
2003;111(6 Pt 3):1601–8.
8. Sicherer SH, Simons FER. Epinephrine for first-aid management of
anaphylaxis. Pediatrics. 2017;139(3).
9. Lieberman PL. Recognition and first-line treatment of anaphylaxis.
Am J Med. 2014;127:S6–11.
Saleheen A. et al.2792
10. Prince BT, Mikhail I, Stukus DR. Underuse of epinephrine for the
treatment of anaphylaxis: missed opportunities. J Asthma Allergy.
2018;11:143–51.
11. What is epinephrine? Mylan. 2019. https://www.epipen.com/en/
about-epipen-and-generic/what-is-epinephrine. Accessed
June 2019.
12. Pepper AN, Westermann-Clark E, Lockey RF. The high cost of
epinephrine autoinjectors and possible alternatives. J Allergy Clin
Immunol Pract. 2017;5(3):665.
13. Rubin R. EpiPen price hike comes under scrutiny. Lancet.
2016;388(10051):1266.
14. Noone SA, Sicherer SH. Patient compliance with self-administered
epinephrine (SAE) for food allergic (FA) children. J Allergy Clin
Immunol. 1999;103(1):S54.
15. Huang SW. A survey of Epi-PEN use in patients with a history of
anaphylaxis. J Allergy Clin Immunol. 1998;102(3):525–6.
16. Patadia DD, Stukus DR. Are expired EpiPens still viable? J Allergy
Clin Immunol Pract. 2017;5(5):1469–70.
17. Rachid O, Simons FER, Wein MB, Rawas-Qalaji M, Simons KJ.
Epinephrine doses contained in outdated epinephrine auto-injectors
collected in a Florida allergy practice. Ann Allergy Asthma
Immunol. 2015;114(4):354.
18. Simons FER, Gu XC, Simons KJ. Outdated EpiPen and EpiPen Jr
autoinjectors: past their prime? J Allergy Clin Immunol.
2000;105(5):1025–30.
19. American Society of Health System Pharmacists. Bethesda, MD:
AHFS Drug Information; 2009.
20. Parish HG, Bowser CS,Morton JR, Brown JC. A systematic review
of epinephrine degradation with exposure to excessive heat or cold.
Ann Allergy Asthma Immunol. 2016;117(1):79–87.
21. Corwin ME, Spencer WH. Conjunctival melanin depositions—a
side-effect of topical epinephrine therapy. AMA Arch
Ophthalmol. 1963;69(3):317.
22. Veirs ER, McGrew JC. Ocular complications from topical epineph-
rine therapy of glaucoma. Eye Ear Nose Throat Mon. 1963;42(9):
46–52.
23. Ferry AP, Zimmerman LE. Black cornea—complication of topical
use of epinephrine. Am J Ophthalmol. 1964;58(2):205.
24. Reinecke RD. Kuwabara T. Corneal deposits secondary to topical
epinephrine. AMA Arch Ophthalmol. 1963;70(2):170.
25. Cleasby G, Donaldson DD. Epinephrine pigmentation of the cor-
nea. JAMA Ophthalmol. 1967;78(1):74–5.
26. Bullock JD. Epinephrine pigmentation. JAMA Ophthalmol.
1970;84(4):546.
27. Bernstein HN. Epinephrine pigmentation—reply. AMA Arch
Ophthalmol. 1970;84(4):546.
28. Garnayak S, Patel S. Oxidation of epinephrine to adrenochrome by
cetyltrimethylammonium dichromate: a mechanistic study. Ind Eng
Chem Res. 2014;53(31):12249–56.
29. https://www.hopkinsmedicine.org/som/wildernessmedicine/index.
html. Accessed 7 Oct 2019.
30. Pietroski N. Expired drugs: immortal or DOA? Wilderness
Medicine Magazine. 2015 November 29.
31. Wang TT, Lio CK, Huang H, Wang RY, Zhou H, Luo P, et al. A
feasible image-based colorimetric assay using a smartphone RGB
camera for point-of-care monitoring of diabetes. Talanta. 2020;206.
32. Sekine Y, Kim SB, Zhang Y, Bandodkar AJ, Xu S, Choi J, et al. A
fluorometric skin-interfaced microfluidic device and smartphone
imaging module for in situ quantitative analysis of sweat chemistry.
Lab Chip. 2018;18(15):2178–86.
33. Mahato K, Chandra P. Paper-based miniaturized immunosensor for
naked eye ALP detection based on digital image colorimetry inte-
grated with smartphone. Biosens Bioelectron. 2019;128:9–16.
34. Hou L, Qin YX, Li JY, Qin SY, Huang YL, Lin TR, et al. A
ratiometric multicolor fluorescence biosensor for visual detection
of alkaline phosphatase activity via a smartphone. Biosens
Bioelectron. 2019;143.
35. Priye A, Ball CS, Meagher RJ. Colorimetric-luminance readout for
quantitative analysis of fluorescence signals with a smartphone
CMOS sensor. Anal Chem. 2018;90(21):12385–9.
36. Minagawa Y, Ueno H, Tabata KV, Noji H. Mobile imaging plat-
form for digital influenza virus counting. Lab Chip. 2019;19(16):
2678–87.
37. Lv SZ, Zhang KY, Tang DP. A new visual immunoassay for
prostate-specific antigen using near-infrared excited CuxS
nanocrystals and imaging on a smartphone. Analyst .
2019;144(12):3716–20.
38. Shan YK, Wang B, Huang HC, Jiang D, Wu XP, Xue L, et al. On-
site quantitative Hg2+ measurements based on selective and sensi-
tive fluorescence biosensor and miniaturized smartphone fluores-
cence microscope. Biosens Bioelectron. 2019;132:238–47.
39. Ravindranath R, PeriasamyAP, Roy P, Chen YW, ChangHT. Smart
app-based on-field colorimetric quantification of mercury via
analyte-induced enhancement of the photocatalytic activity of
TiO2-Au nanospheres. Anal Bioanal. 2018;410(18):4555–64.
40. Lee WI, Park Y, Park J, Shrivastava S, Son YM, Choi HJ, et al. A
smartphone fluorescence imaging-based mobile biosensing system
integrated with a passive fluidic control cartridge for minimal user
intervention and high accuracy. Lab Chip. 2019;19(8):1502–11.
41. Convention USP. USP35 NF30, 2012: U. S. Pharmacopoeia
National Formulary. United States Pharmacopeial; 2011.
42. Xiaoqian W, Fan F, Jiatong S, Lu W, Srivastava A, Chigrinov VG.
Evaluation of LC Fresnel phase plate utilized as colour filter. 2012.
43. Cheremkhin PA, Lesnichii VV, Petrov NV. Use of spectral charac-
teristics of DSLR cameras with Bayer filter sensors. J Phys Conf
Ser. 2014;536:012021.
44. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M,
Pietzsch T, et al. Fiji: an open-source platform for biological-image
analysis. Nat Methods. 2012;9:676.
45. Watters RL, Carroll RJ, Spiegelman CH. Error modeling and con-
fidence interval estimation for inductively coupled plasma calibra-
tion curves. Anal Chem. 1987;59(13):1639–43.
46. Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein
D, Bernstein J, et al. Anaphylaxis—a practice parameter update
2015. Ann Allergy Asthma Immunol. 2015;115(5):341–84.
47. The United States Pharmacopeia: USP 24: the National Formulary:
NF 19 : by authority of the United States Pharmacopoeial
Convention, Inc., meeting at Washington, D.C., March 9–12,
1995 ; prepared by the Committee of Revision and published by
the Board of Trustees. Rockville, Md.: United States Pharmacopeial
Convention; 1999.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Estimation of available epinephrine dose in expired and discolored autoinjectors via quantitative... 2793
